|
|
Volumn 49, Issue 3, 1991, Pages 278-284
|
|
Inhibition of antipyrine metabolism by low-dose contraceptives with gestodene and desogestrel
a
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
APOLIPOPROTEIN;
DESOGESTREL;
GESTODENE;
HIGH DENSITY LIPOPROTEIN;
LIPOPROTEIN;
ORAL CONTRACEPTIVE AGENT;
PHENAZONE;
ADULT;
ARTICLE;
DRUG METABOLISM;
FEMALE;
HUMAN;
HUMAN EXPERIMENT;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
TRIACYLGLYCEROL BLOOD LEVEL;
BIOLOGY;
CONTRACEPTION;
CONTRACEPTIVE METHODS--PHARMACODYNAMICS;
DEVELOPED COUNTRIES;
EUROPE;
EXAMINATIONS AND DIAGNOSES;
FAMILY PLANNING;
ITALY;
LABORATORY EXAMINATIONS AND DIAGNOSES;
LIPID METABOLIC EFFECTS--CHANGES;
LIPIDS;
MEDITERRANEAN COUNTRIES;
ORAL CONTRACEPTIVES--PHARMACODYNAMICS;
PHYSIOLOGY;
SOUTHERN EUROPE;
ADULT;
ANTIPYRINE;
COMPARATIVE STUDY;
CONTRACEPTIVES, ORAL;
DESOGESTREL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMAN;
LIPIDS;
LIPOPROTEINS;
LIPOPROTEINS, HDL CHOLESTEROL;
NORPREGNENES;
SUPPORT, NON-U.S. GOV'T;
|
|
EID: 0026031826
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.1991.29 Document Type: Article |
|
Times cited : (18)
|
|
References (38)
|
